The use and development of germline polymorphisms in clinical oncology.
Lenz
Heinz-Josef
HJ
D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000473:pathology*; D004265:DNA Helicases; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins / Q000235:genetics; D018095:Germ-Line Mutation; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology*; D008495:Medical Oncology / Q000639:trends; D011110:Polymorphism, Genetic; D011379:Prognosis; D011506:Proteins / Q000235:genetics; D014157:Transcription Factors; D000076105:X-ray Repair Cross Complementing Protein 1; D051759:Xeroderma Pigmentosum Group D Protein
D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D011506:Proteins; D014157:Transcription Factors; D000076105:X-ray Repair Cross Complementing Protein 1; D004265:DNA Helicases; D051759:Xeroderma Pigmentosum Group D Protein; C497292:ERCC2 protein, human